Mixed Mode Chromatography Resin Market Size, Share & Trends Analysis Report By Technique (Ion Exchange-Hydrophobic, Hydroxyapatite), By End-use (Pharmaceutical & Biotechnology), By Region, And Segment Forecasts, 2025 - 2030

October 2024 | 80 pages | ID: MAA213180ABEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Mixed Mode Chromatography Resin Market Growth & Trends

The global mixed mode chromatography resin market size is expected treach USD 223.9 million by 2030, registering a CAGR of 12.3% from 2025 t2030, according ta new report by Grand View Research, Inc. Growing number of contract manufacturing organizations (CMOs) and contract research organizations (CROs), along with increasing use of chromatography resin in separation of monoclonal antibodies, is anticipated tpropel the market.

The Ion exchange - Hydrophobic resin segment is expected tdominate the global market till 2025. Demand for this technique is attributed tgrowth in drug discovery by pharmaceutical companies. These companies use chromatography techniques tseparate complex mixtures and purification of materials. Increasing number of epidemic diseases such as Zika and Ebola is expected tfurther boost the mixed mode chromatography resin market.

Asia Pacific, especially China and India, is expected tgenerate significant demand for mixed mode chromatography resin owing tgrowing pharmaceutical sector, coupled with abundance of high skilled workforce and increase in disposable income.

Presence of global pharmaceutical and biotechnology companies, along with their research and development facilities, has enabled North America tbe a key market for mixed mode chromatography resin. Massive healthcare expenditure is alsdriving the expansion of the market in this region.

Mixed Mode Chromatography Resin Market Report Highlights
        • The pharmaceutical and biotechnology segment led the market and is expected tgrow at a CAGR of 12.3% from 2025 t2030, owing tincreasing investments in biopharmaceutical research and development, particularly for novel therapies like monoclonal antibodies and gene therapies, heightening the demand for effective purification techniques.
    • The ion exchange and hydrophobic interaction segment dominated the market and accounted for the largest revenue share of 50.8% in 2024 attributed tits effectiveness in separating biomolecules based on charge and hydrophobicity.
    • The mixed mode chromatography resin market in North America dominated the global market and accounted for the largest revenue share of 35.3% in 2024 attributed tthe strong presence of pharmaceutical and biotechnology companies.
      • The mixed mode chromatography resin market in Asia Pacific is expected tgrow at a CAGR of 8.3% over the forecast period. This growth is attributed tincreasing investments in biopharmaceuticals and rising healthcare expenditures.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
  1.3.1. Purchased Database
  1.3.2. GVR’s Internal Database
  1.3.3. Secondary Sources & Third-Party Perspectives
  1.3.4. Primary Research
1.4. Information Analysis
  1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Insights
2.2. Segmental Outlook
2.3. Competitive Outlook

CHAPTER 3. MIXED MODE CHROMATOGRAPHY RESIN MARKET VARIABLES, TRENDS & SCOPE

3.1. Global Mixed Mode Chromatography Resin Market Outlook
3.2. Industry Value Chain Analysis
3.3. Technology Overview
3.4. Average Price Trend Analysis
3.5. Supply-Demand GAP Analysis, 2024
3.6. Regulatory Framework
  3.6.1. Policies and Incentive Plans
  3.6.2. Standards and Compliances
  3.6.3. Regulatory Impact Analysis
3.7. Market Dynamics
  3.7.1. Market Driver Analysis
  3.7.2. Market Restraint Analysis
  3.7.3. Industry Challenges
3.8. Porter’s Five Forces Analysis
  3.8.1. Supplier Power
  3.8.2. Buyer Power
  3.8.3. Substitution Threat
  3.8.4. Threat from New Entrant
  3.8.5. Competitive Rivalry
3.9. PESTEL Analysis
  3.9.1. Political Landscape
  3.9.2. Economic Landscape
  3.9.3. Social Landscape
  3.9.4. Technological Landscape
  3.9.5. Environmental Landscape
  3.9.6. Legal Landscape

CHAPTER 4. MIXED MODE CHROMATOGRAPHY RESIN MARKET: TECHNIQUE OUTLOOK ESTIMATES & FORECASTS

4.1. Mixed Mode Chromatography Resin Market: Technique Movement Analysis, 2024 & 2030
  4.1.1. Ion exchange - Hydrophobic
    4.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
  4.1.2. Hydroxyapatite
    4.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
  4.1.3. Others
    4.1.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)

CHAPTER 5. MIXED MODE CHROMATOGRAPHY RESIN MARKET: END USE OUTLOOK ESTIMATES & FORECASTS

5.1. Mixed Mode Chromatography Resin Market: End Use Movement Analysis, 2024 & 2030
  5.1.1. Pharmaceutical & Biotechnology
    5.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)

CHAPTER 6. MIXED MODE CHROMATOGRAPHY RESIN MARKET REGIONAL OUTLOOK ESTIMATES & FORECASTS

6.1. Regional Snapshot
6.2. Mixed Mode Chromatography Resin Market: Regional Movement Analysis, 2024 & 2030
6.3. North America
  6.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.3.1.1. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.3.1.2. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.3.2. U.S.
    6.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.3.2.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.3.2.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
6.4. Europe
  6.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.1.1. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.1.2. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.4.2. UK
    6.4.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.2.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.2.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.4.3. Germany
    6.4.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.3.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.3.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.4.4. France
    6.4.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.4.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.4.4.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
6.5. Asia Pacific
  6.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.1.1. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.1.2. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.5.2. China
    6.5.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.2.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.2.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.5.3. India
    6.5.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.3.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.3.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.5.4. Japan
    6.5.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.4.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.4.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)
  6.5.5. South Korea
    6.5.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.5.2. Market Estimates and Forecast, by Technique, 2018 - 2030 (USD Million) (Thousand Liters)
    6.5.5.3. Market Estimates and Forecast, by End Use, 2018 - 2030 (USD Million) (Thousand Liters)

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Vendor Landscape
  7.2.1. Company categorization
  7.2.2. List of Key Distributors and channel Partners
  7.2.3. List of Potential Customers/End Users
7.3. Competitive Dynamics
  7.3.1. Competitive Benchmarking
  7.3.2. Strategy Mapping
  7.3.3. Heat Map Analysis
7.4. Company Profiles/Listing
  7.4.1. GE Healthcare Lifesciences
    7.4.1.1. Participant’s Overview
    7.4.1.2. Financial Performance
    7.4.1.3. Technique Benchmarking
    7.4.1.4. Strategic Initiatives
  7.4.2. Merck KGaA
    7.4.2.1. Participant’s Overview
    7.4.2.2. Financial Performance
    7.4.2.3. Technique Benchmarking
    7.4.2.4. Strategic Initiatives
  7.4.3. Tosoh Corp
    7.4.3.1. Participant’s Overview
    7.4.3.2. Financial Performance
    7.4.3.3. Technique Benchmarking
    7.4.3.4. Strategic Initiatives
  7.4.4. Purolite Corp
    7.4.4.1. Participant’s Overview
    7.4.4.2. Financial Performance
    7.4.4.3. Technique Benchmarking
    7.4.4.4. Strategic Initiatives
  7.4.5. Danaher Corp.
    7.4.5.1. Participant’s Overview
    7.4.5.2. Financial Performance
    7.4.5.3. Technique Benchmarking
    7.4.5.4. Strategic Initiatives
  7.4.6. JSR Micro Inc.
    7.4.6.1. Participant’s Overview
    7.4.6.2. Financial Performance
    7.4.6.3. Technique Benchmarking
    7.4.6.4. Strategic Initiatives
  7.4.7. Bio-Rad Labs
    7.4.7.1. Participant’s Overview
    7.4.7.2. Financial Performance
    7.4.7.3. Technique Benchmarking
    7.4.7.4. Strategic Initiatives
  7.4.8. Purolite
    7.4.8.1. Participant’s Overview
    7.4.8.2. Financial Performance
    7.4.8.3. Technique Benchmarking
    7.4.8.4. Strategic Initiatives
  7.4.9. Sepragen Corporation
    7.4.9.1. Participant’s Overview
    7.4.9.2. Financial Performance
    7.4.9.3. Technique Benchmarking
    7.4.9.4. Strategic Initiatives
  7.4.10. Thermo Fisher Scientific
    7.4.10.1. Participant’s Overview
    7.4.10.2. Financial Performance
    7.4.10.3. Technique Benchmarking
    7.4.10.4. Strategic Initiatives


More Publications